Live Programs

Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis
Live Virtual Webinar:
Wednesday, January 18, 2023 at 7:00 PM EST


New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Live Virtual Webinar:
Wednesday, November 30, 2022 at 7:00 PM EST


Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy
Live Virtual Webinar:
Tuesday, October 4, 2022 at 7:00 PM EDT


Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
Live Virtual Webinar
Wednesday, August 31, 2022, at 7 PM EDT /4 PM PDT
Rebroadcasts:
1) Saturday, September 3, 2022, at 1 pm EDT
2) Tuesday, September 6, 2022, at 7 pm EDT
3) Thursday, September 8, 2022, at 7 pm EDT
4) Saturday, September 10, 2022, at 1 pm EDT


Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors
Live Virtual Webinar
Thursday, August 18, 2022, at 7 pm EDT/ 4 PM PDT
Rebroadcasts:
1) Saturday, August 20, 2022, at 1 pm EDT/ 10 AM PDT
2) Tuesday, August 23, 2022, at 7 pm EDT/ 4 PM PDT
3) Thursday, August 25, 2022, at 7 pm EDT/ 4 PM PDT
4) Saturday, August 27, 2022, at 1 pm EDT/ 10 AM PDT


Emerging Treatment Options for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Live Virtual Webinar
Wednesday, June 15, 2022, at 7 PM EDT /4 PM PDT
Rebroadcasts:
1) Monday, June 20, at 7pm EDT/4 PM PDT
2) Saturday, June 25, 2022, at 12 PM EDT/9 AM PDT
3) Wednesday, June 29, 2022, at 1 PM EDT /10 AM PDT
4) Thursday, June 30, 2022, at 7pm EDT/4 PM PDT


Current and Emerging Treatment Options for Multiple Myeloma
Live Virtual Webinar
Saturday, April 2, 2022, at 10 am EDT
Rebroadcast: Saturday, April 16, 2022, at 10 am EDT


Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Live Virtual Webinar
Monday, March 14, 2022, at 6:30 pm EDT
Rebroadcast: Thursday, March 24, 2022, at 6:30 pm EDT


Novel Treatment Options for Multiple Myeloma
Live Virtual Webinar
Tuesday, February 22, 2022, at 6:00 pm EST
Rebroadcast: Thursday, March 3, 2022 at 6:00 pm EST


Emerging Strategies in the Treatment of Genitourinary Cancers
Live Virtual Webinar
Thursday, November 11, 2021 at 7 pm ET/6 CDT
Rebroadcast: Saturday, November 20, 2021 at 2 pm ET/1 CDT


Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Live Virtual Webinar
Saturday, October 30 at 10am Eastern
Rebroadcast: Saturday, November 6 at 2pm Eastern


Novel Therapies for Metastatic Castrate Resistant Prostate Cancer with PARP-Inhibitors and BITE Immunotherapy
Live Virtual Webinar
October 6, 2021, 7pm - 8:30pm EDT
Rebroadcast: October 20, 2021, 2021, 7pm - 8:30pm EDT


Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Live Virtual Webinar
September 29, 2021, 7pm - 8:30pm EDT
Rebroadcast: October 11, 2021, 2021, 7pm - 8:30pm EDT


Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Live Virtual Webinar
August 18, 2021, 7pm - 8:30pm EDT
Rebroadcast: August 26, 2021, 7pm - 8:30pm EDT


New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Live Virtual Webinar


New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Live Virtual Webinar


Changing Landscape of Treatment for Acute Lymphoblastic Leukemia
Live Virtual Webinar


New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
April 27, 2019
Houston, TX


Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
October 27, 2018
Houston, TX


Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Castrate Resistant Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)
September 22, 2018
Houston, TX


7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
June 23, 2018
Houston, TX


3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis
September 10, 2016
Houston, TX


Biological Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Osteoarthritis: Comparative Effectiveness Based on Treatment Profiles and Guideline Recommendations

September 19, 2015
Philadelphia, PA


2nd Annual Symposium on Current Strategies in the Diagnosis and Treatment of Multiple Sclerosis 

April 11, 2015
Dallas, TX